Original Articles
Vol. 9 No. 1 (2026)
Letrozole and metformin versus letrozole alone for ovulation induction in women with polycystic ovarian syndrome: a randomised controlled trial
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 27 August 2024
Accepted: 6 December 2024
Accepted: 6 December 2024
57
Views
34
Downloads
Authors
Polycystic ovary syndrome is a syndrome with a complex interaction between metabolic, endocrine, genetic, and environmental factors. The aim of the study is to compare letrozole and metformin with letrozole alone for ovulation induction.
This was a single blinded randomized controlled trial. Patients who met the inclusion criteria and consented for the study were recruited and randomized into study and control groups. The study group were placed on metformin 1000 mg daily and letrozole 7.5 mg daily from the second to the sixth day of the menstrual cycle, while the control group received letrozole 7.5 mg from the second day to the sixth day. Outcome measures recorded were ovulation, conception and pregnancy.
The ovulation rate was 75.8% in metformin and letrozole group and 78.8% in letrozole alone group, conception rate was 42.4% and 33.3% respectively while pregnancy rate was 27.3% and 24.2% respectively.
There was a higher ovulation rate in letrozole alone group than in combined letrozole and metformin, while conception rate and pregnancy rate was higher in the combined letrozole and metformin.
Downloads
Download data is not yet available.
Citations
1. Mejia RB, Summers KM, Kresowik JD, Van Voorhis BJ. A randomised controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with PCOS. Rep Endocrinology 2019;111:571-8. DOI: https://doi.org/10.1016/j.fertnstert.2018.11.030
2. Yakasai IA, Tukur J. Polycystic Ovary Syndrome. Comprehensive Gynaecology in the Tropics 2017;37:435-9.
3. Akpata CB, Uadia PO, Okonofua FE. Prevalence of polycystic ovary syndrome in Nigerian women with infertility: a prospective study of the three assessment criteria. Open Journal of Obstetrics and Gynecology 2018;8:1109-20. DOI: https://doi.org/10.4236/ojog.2018.812112
4. Lagana AS, Vitale SG, Noventa M, Vitagliano A. Current management of polycystic ovary syndrome: from bench to bedside. Hindawi International Journal of Endocrinology 2018;3:115-20. DOI: https://doi.org/10.1155/2018/7234543
5. Kuang H, Jin S, Hansen KR, et al. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome. Human Reproduction Oxford England 2015;30:2222-33. DOI: https://doi.org/10.1093/humrep/dev182
6. Rosenfield R, Ehrmann DA. The pathogenesis of polycystic ovary syndrome: the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine Reviews 2016;37:467-520. DOI: https://doi.org/10.1210/er.2015-1104
7. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. FertilSteril 2004;81:19-25. DOI: https://doi.org/10.1016/j.fertnstert.2003.10.004
8. Mohsin R, Said A, Muhammad M, Mohsin K. Role of letrozole and metformin vs letrozole alone in ovulation induction in patients of polycystic ovarian syndrome PJMHS 2019;13:350-2.
9. Tanbo T, Mellembakken J, Bjercke S, et al. Ovulation induction in polycystic ovary syndrome. Acta ObstetGynecolScand 2018;97:1162-7. DOI: https://doi.org/10.1111/aogs.13395
10. Alizzi FJ, Showman HA K, Fawzi HA. Predictors for response to letrozole as an ovulation induction in anovulatory infertile polycystic ovarian syndrome women. Iraqi Journal of Embryos and Infertility Researches 2019;9:89-110. DOI: https://doi.org/10.28969/IJEIR.v9.i1.r6
11. Sivalingam VN, Myers J, Nicholas S, et al. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Hum Reprod Update 2014;20:853-68. DOI: https://doi.org/10.1093/humupd/dmu037
12. Morley LC, Tang T, Yasmin E, et al. Insulin- sensitising drugs (metformin, rosiglitazone, pioglitazone, d-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2017;11:30-53. DOI: https://doi.org/10.1002/14651858.CD003053.pub6
13. Ugwu GO, Iyoke CA, Onah HE, Mba SG. Prevalence, presentation and management of polycystic ovary syndrome in Enugu, southeast Nigeria. Niger J Med 2013; 22:313‐6.
14. Goodman NF, Cobin RH, Futterweit W, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome. EndocrPract 2015;21:1415-26. DOI: https://doi.org/10.4158/EP15748.DSCPT2
15. Balen AH, Marley LC, Missom M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Human Reproduction Update 2016;22:687-708. DOI: https://doi.org/10.1093/humupd/dmw025
16. Gadalla MA, Norman RJ, Tay CT, et al. Medical and surgical treatment of reproductive outcomes in polycystic ovary syndrome: an overview of systematic reviews. Int J FertilSteril 2020;13:257-70.
17. Dewailly D, Pigny P, Soudan B, et al. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Mullerian hormone concentrations aggregate with the markers of hyperandrogenism. J Clin Endocrinol Metab 2010;95:4399-405. DOI: https://doi.org/10.1210/jc.2010-0334
18. Ramezanzadeh F, Nasiri R, Yazdi MS, Baghreri M. A randomised trial of ovulation induction with two different doses of Letrozole in women with PCOS. Archives of Gynaecology & Obstetrics 2011;284:1029. DOI: https://doi.org/10.1007/s00404-011-1951-5
19. Teede H, Deeks A, Moral L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestation that it impacts on health across the lifespan. BMJ Medicine 2010;41:1741-7015-8-41. DOI: https://doi.org/10.1186/1741-7015-8-41
20. Franik S, Eltrop SM, Kremer JAM, et al. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2018;5:CD010287. DOI: https://doi.org/10.1002/14651858.CD010287.pub3
21. Legro RS, Kunselman AR, Brzyski RG, et al. The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of Clomiphene citrate and Letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemp Clin Trials 2012;33:470-81. DOI: https://doi.org/10.1016/j.cct.2011.12.005
22. Sohrabvand F, Ansari SH, Bagheri M. Efficacy of combined metformin–letrozole in comparison with metformin–clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction 2006;21:1432-5. DOI: https://doi.org/10.1093/humrep/del020
23. Pritts EA, Alexander KY, Sharma S, et al. The use of high dose letrozole in ovulation induction and controlled ovarian hyperstimulation. ISRN Obstet Gynecol 2011:242864. DOI: https://doi.org/10.5402/2011/242864
24. Moustafa I, Rowaa AM, Ahmed AA. Letrozole versus clomiphene citrate for superovulation in Egyptian women with unexplained infertility: a randomised controlled trial. Archives of Gynaecology and Obstetrics 2012;286:1581-7. DOI: https://doi.org/10.1007/s00404-012-2478-0
25. Owen M. Physiological signs of ovulation and fertility readily observable by women. The Linacre Quarterly 2013;80:17-23. DOI: https://doi.org/10.1179/0024363912Z.0000000005
26. Morley LC, Tang TMH, Balen AH, on behalf of Royal College of Obstetrics and Gynaecology. Metformin therapy for the management of infertility in women with PCOS. BJOG 2017;124:306-13. DOI: https://doi.org/10.1111/1471-0528.14764
27. Su HW, Yi YC, Wei TY, et al. Detection of ovulation, a review of currently available methods. BioengTransl Med 2017;2:238-46. DOI: https://doi.org/10.1002/btm2.10058
28. Amer SA, Smith J, Mahran A, et al. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction 2017;32:1631-8. DOI: https://doi.org/10.1093/humrep/dex227
29. Legro RS, Bryski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014;371:119-29. DOI: https://doi.org/10.1056/NEJMoa1313517
30. Bolarinwa OA. Sample size estimation for health and social science researchers: the principles and considerations for different study designs. Niger Postgrad Med J 2020;27:67‐75. DOI: https://doi.org/10.4103/npmj.npmj_19_20
31. Davar R, Javedani M, Fallahzadeh MH. Metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene resistance PCOS patients undergoing IUI. Iran J Reprod Med 2011;9:31-6.
32. Leui C, Guimei F, Wei H, et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology 2017;33:872-6. DOI: https://doi.org/10.1080/09513590.2017.1332174
33. Hurley SR, Adams N, Kalakota JM, et al. The addition of metformin during ovulation induction with letrozole does not affect pregnancy outcome in infertile women with polycystic ovary syndrome. ASRM 2017;108:366. DOI: https://doi.org/10.1016/j.fertnstert.2017.07.740
34. Davar R, Maryam MD, Asgharnia M, et al. Comparison of the use of letrozole and clomiphene citrate in regularly ovulating women undergoing intrauterine insemination. Middle East Fertility Society Journal 2006;11:346-9.
35. Elgafor IA. Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene resistant infertile women with polycystic ovarian syndrome. Arch Gynecol Obstet 2013;288:119-23. DOI: https://doi.org/10.1007/s00404-013-2714-2
36. Li M, Ruan X, Mueck AO. Management strategy of infertility in polycystic ovary syndrome. Global Health Journal 2022;3:70-4. DOI: https://doi.org/10.1016/j.glohj.2022.03.002
37. Notaro ALG, Neto FTL. The use of metformin in women with polycystic ovary syndrome. J Assist Reprod Genet 2022;39:573-5. DOI: https://doi.org/10.1007/s10815-022-02429-9
How to Cite
“Letrozole and Metformin Versus Letrozole Alone for Ovulation Induction in Women With Polycystic Ovarian Syndrome: A Randomised Controlled Trial”. 2026. Pyramid Journal of Medicine 9 (1). https://doi.org/10.4081/pjm.2026.514.
Copyright (c) 2026 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.